| Biography:
Colin Underwood is a partner in the Litigation and Dispute Resolution Department and serves as Co-Chair of the Proskauer’s Antitrust Practice Group. He is resident in the New York office.
Colin’s practice focuses on complex commercial litigation, with an emphasis on antitrust and intellectual property. He has extensive experience in representing clients in the pharmaceutical industry in all types of disputes, from patent infringement litigation to contract disputes. In 2006, he obtained a major litigation victory for a small biotechnology client asserting breach of contract claims against a major pharmaceutical manufacturer. He also successfully represented another biotechnology client in an international arbitration to resolve a licensing dispute. Colin has also litigated on behalf of a generic pharmaceutical company asserting antitrust claims against another generic manufacturer for having delayed its competitor’s entry into the market.
In 2007, Colin represented a major French cellular telephone company in litigation against the provider of network equipment that had failed, taking the telephone system out of service.
More recently, Colin represented the men’s professional tennis tour, ATP Tour, Inc., against antitrust claims brought by the owners of Hamburg tennis tournament. After a two-week jury trial, the ATP prevailed on all counts.
Colin has also advised clients on antitrust compliance issues and in connection with merger analysis, and has represented clients before the Antitrust Division and the FTC.
Prior to entering private practice, Colin served as a law clerk for the Honorable Robert W. Sweet in the United States District Court, Southern District of New York.
Colin received his J.D. from Yale Law School in 1990, where he served as Production Editor of the Yale Law Journal. He earned his B.Sc. in mathematics and computer science from the University of Michigan in 1984 and his M.S. in computer science from the University of Michigan in 1985.
Colin is a member of the Executive Committee of the Antitrust Section of the New York State Bar Association and he also belongs to the Intellectual Property and International Law and Practice Sections. He is also a member of the American Bar Association, where he belongs to the Antitrust, Intellectual Property and Litigation Sections, and to the Committee on Antitrust Litigation. Colin also serves on the Advisory Board of the BNA Pharmaceutical Law and Industry Report.
Reported cases:
Eli Lilly & Co. v. Emisphere Technologies, Inc., 408 F. Supp. 668 (S.D. Ind. 2006)
Geneva Pharmaceuticals Tech. Corp. v. Barr Labs., Inc., 386 F.2d 485 (2d Cir. 2004)
|
